Investigating a protein's role in healing corneal wounds and preventing scarring
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis
This study is looking at a protein called Prolactin-Induced Protein (PIP) to see how it helps heal eye injuries and prevent scarring that can cause vision problems, with the hope of finding new treatments that could reduce the need for surgeries like corneal transplants.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-11049118 on NIH RePORTER |
What this research studies
This research focuses on the role of Prolactin-Induced Protein (PIP) in healing corneal wounds and preventing fibrosis, which can lead to blindness. The study aims to understand how PIP interacts with other proteins involved in scarring and its potential as a therapeutic target. By conducting both laboratory and clinical studies, researchers will explore PIP's effects on cellular processes related to corneal health. Patients may benefit from new treatments that reduce the need for invasive surgeries like corneal transplants.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from corneal diseases or injuries that may lead to scarring and vision loss.
Not a fit: Patients with corneal conditions that are not related to scarring or those who have already undergone corneal transplantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve corneal healing and reduce blindness caused by scarring.
How similar studies have performed: Previous studies have shown promising results with similar approaches targeting proteins involved in wound healing and fibrosis, indicating potential for success in this area.
Where this research is happening
Fort Worth, United States
- University of North Texas Hlth Sci Ctr — Fort Worth, United States (Active)
Researchers
- Principal investigator: Karamichos, Dimitrios — University of North Texas Hlth Sci Ctr
- Study coordinator: Karamichos, Dimitrios
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.